Henry Schein Inc (HSIC) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Distribution industry.
Over the past 4 years, Henry Schein Inc has achieved a revenue compound annual growth rate (CAGR) of 41.4%, while earnings have grown at -1.3% CAGR.
Historical revenue and profitability trends for Henry Schein Inc
The chart above illustrates Henry Schein Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Henry Schein Inc's business.
How efficiently Henry Schein Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Henry Schein Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Henry Schein Inc to continue growing earnings in the coming year. The consensus analyst rating is 3.5 based on 16 analysts.
Based on our comprehensive analysis, Henry Schein Inc (HSIC) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Henry Schein Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Henry Schein Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: HSIC Valuation, HSIC Dividend, HSIC Financial Health
Compare: HSIC vs AAPL, HSIC vs MSFT, HSIC vs GOOGL